Veracyte PE Ratio 2012-2024 | VCYT
Current and historical p/e ratio for Veracyte (VCYT) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Veracyte PE ratio as of August 30, 2024 is 150.24.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Veracyte PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2024-08-30 | 31.55 | 0.00 | |
2024-06-30 | 21.67 | $-0.75 | 0.00 |
2024-03-31 | 22.16 | $-0.94 | 0.00 |
2023-12-31 | 27.51 | $-1.03 | 0.00 |
2023-09-30 | 22.33 | $-0.69 | 0.00 |
2023-06-30 | 25.47 | $-0.40 | 0.00 |
2023-03-31 | 22.30 | $-0.41 | 0.00 |
2022-12-31 | 23.73 | $-0.50 | 0.00 |
2022-09-30 | 16.60 | $-0.60 | 0.00 |
2022-06-30 | 19.90 | $-0.68 | 0.00 |
2022-03-31 | 27.57 | $-0.68 | 0.00 |
2021-12-31 | 41.20 | $-1.14 | 0.00 |
2021-09-30 | 46.45 | $-1.13 | 0.00 |
2021-06-30 | 39.98 | $-1.01 | 0.00 |
2021-03-31 | 53.75 | $-1.10 | 0.00 |
2020-12-31 | 48.94 | $-0.68 | 0.00 |
2020-09-30 | 32.49 | $-0.69 | 0.00 |
2020-06-30 | 25.90 | $-0.63 | 0.00 |
2020-03-31 | 24.31 | $-0.46 | 0.00 |
2019-12-31 | 27.92 | $-0.27 | 0.00 |
2019-09-30 | 24.00 | $-0.20 | 0.00 |
2019-06-30 | 28.51 | $-0.30 | 0.00 |
2019-03-31 | 25.02 | $-0.43 | 0.00 |
2018-12-31 | 12.58 | $-0.65 | 0.00 |
2018-09-30 | 9.55 | $-0.81 | 0.00 |
2018-06-30 | 9.34 | $-0.90 | 0.00 |
2018-03-31 | 5.56 | $-0.94 | 0.00 |
2017-12-31 | 6.53 | $-0.91 | 0.00 |
2017-09-30 | 8.77 | $-0.81 | 0.00 |
2017-06-30 | 8.33 | $-0.80 | 0.00 |
2017-03-31 | 9.18 | $-0.98 | 0.00 |
2016-12-31 | 7.74 | $-1.10 | 0.00 |
2016-09-30 | 7.61 | $-1.25 | 0.00 |
2016-06-30 | 5.03 | $-1.37 | 0.00 |
2016-03-31 | 5.40 | $-1.32 | 0.00 |
2015-12-31 | 7.20 | $-1.30 | 0.00 |
2015-09-30 | 4.69 | $-1.37 | 0.00 |
2015-06-30 | 11.14 | $-1.42 | 0.00 |
2015-03-31 | 7.28 | $-1.38 | 0.00 |
2014-12-31 | 9.66 | $-1.36 | 0.00 |
2014-09-30 | 9.75 | $-1.42 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $2.423B | $0.361B |
Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
Alcon (ALC) | Switzerland | $48.180B | 33.92 |
IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
DexCom (DXCM) | United States | $27.786B | 39.62 |
STERIS (STE) | Ireland | $23.777B | 27.74 |
SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
Waters (WAT) | United States | $20.560B | 30.65 |
Hologic (HOLX) | United States | $18.870B | 20.52 |
Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
Teleflex (TFX) | United States | $11.552B | 17.96 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
Globus Medical (GMED) | United States | $9.844B | 27.54 |
Penumbra (PEN) | United States | $7.859B | 81.58 |
Glaukos (GKOS) | United States | $7.357B | 0.00 |
Masimo (MASI) | United States | $6.252B | 33.48 |
TransMedics (TMDX) | United States | $5.606B | 240.09 |
Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
Inari Medical (NARI) | United States | $2.519B | 0.00 |
Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
RxSight (RXST) | United States | $2.086B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
OPKO Health (OPK) | United States | $1.172B | 0.00 |
Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
Artivion (AORT) | United States | $1.137B | 104.38 |
AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
Paragon 28 (FNA) | United States | $0.695B | 0.00 |
SiBone (SIBN) | United States | $0.693B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
IRadimed (IRMD) | United States | $0.595B | 32.16 |
AxoGen (AXGN) | United States | $0.576B | 0.00 |
Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
Inogen (INGN) | United States | $0.291B | 0.00 |
NeuroPace (NPCE) | United States | $0.231B | 0.00 |
Nevro (NVRO) | United States | $0.231B | 0.00 |
Accuray (ARAY) | United States | $0.216B | 0.00 |
CVRx (CVRX) | United States | $0.215B | 0.00 |
Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
908 Devices (MASS) | United States | $0.137B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
Hyperfine (HYPR) | United States | $0.073B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
InspireMD (NSPR) | Israel | $0.069B | 0.00 |
Envoy Medical (COCH) | United States | $0.059B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
LENSAR (LNSR) | United States | $0.054B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
Precision Optics (POCI) | United States | $0.032B | 0.00 |
ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
Neuronetics (STIM) | United States | $0.027B | 0.00 |
Spectral AI (MDAI) | United States | $0.025B | 0.00 |
DarioHealth (DRIO) | United States | $0.024B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
PAVmed (PAVM) | United States | $0.009B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.004B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |